Wound Vitality Markers in Forensic Pathology
PLAIES VITALES
1 other identifier
observational
57
1 country
1
Brief Summary
The purpose is to determine intrinsic properties of various immunohistochemical markers (FVIIIra, CD15, CD30, tryptase, TNFα, IL-1β, TGFα et TGFβ1) for diagnosis of vital wound, alone and in association (evaluation of sensibility with surgery wounds and evaluation of specificity with post-mortem wounds). Secondary purposes are to measure the minimum time to obtain a positive labeling in vital wounds, and to evaluate inter-observer reproducibility of vitality diagnosis with different markers. Expression of microRNA miR 9, miR 21 et miR 198 will be also studied.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Dec 2014
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2014
CompletedFirst Submitted
Initial submission to the registry
September 2, 2016
CompletedFirst Posted
Study publicly available on registry
September 8, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2016
CompletedSeptember 8, 2016
September 1, 2016
2 years
September 2, 2016
September 2, 2016
Conditions
Outcome Measures
Primary Outcomes (2)
Sensibility of markers for vitality diagnosis
baseline
Specificity of markers for vitality diagnosis
baseline
Secondary Outcomes (5)
Minimum time to obtain a labeling (between incision and devascularization)
baseline
Coefficient of inter-observer correlation of vitality diagnosis (for reproducibility analysis)
baseline
Expression level of miR 9 by qRT-PCR
baseline
Expression level of miR 21 by qRT-PCR
baseline
Expression level of miR 198 by qRT-PCR
baseline
Study Arms (2)
Vital wounds
from abdominoplasty of alive persons
Post-mortem wounds
from autopsy of deceased persons
Interventions
Eligibility Criteria
Patients operated in Plastic and Reconstructive Surgery and Maxillofacial Surgery departments at CHRU Nancy for therapeutic abdominoplasty. Deceased patients, whose medico-scientific autopsies are performed for diagnosis in Anatomy and Pathological Cytology or Legal Medicine departments.
You may qualify if:
- Alive persons:
- \- Abdominoplasty
- Deceased persons:
- \- Medico-scientific autopsy for diagnosis
You may not qualify if:
- Alive persons:
- Fragmented sample with non-visible banks
- Cutaneous pathology
- Deceased persons:
- Persons under protection
- Medico-legal obstacle
- Cutaneous pathology
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHRU Nancy
Nancy, France
Biospecimen
Cutaneous tissue
MeSH Terms
Conditions
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Laurent MARTRILLE
Service de Médecine Légale - CHRU de Nancy
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 2, 2016
First Posted
September 8, 2016
Study Start
December 1, 2014
Primary Completion
December 1, 2016
Study Completion
December 1, 2016
Last Updated
September 8, 2016
Record last verified: 2016-09
Data Sharing
- IPD Sharing
- Will not share